Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Future Oncology (London, England)|March 12, 2015
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patientsOrazio Caffo, Giovanni Lo Re, Teodoro Sava, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2024
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real lifeMichele Reni, Guido Giordano, Marco Audisio, et al.The Oncologist|June 2, 2019
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE StudyMaria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, et al.Clinical Genitourinary Cancer|January 22, 2017
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA StudySebastiano Buti, Melissa Bersanelli, Francesca Maines, et al.Targeted Oncology|June 25, 2022
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR StudyMarco Maruzzo, Francesco Pierantoni, Alberto Bortolami, et al.Journal of Translational Medicine|March 5, 2024
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patientsGiulia Pasello, Aline S C Fabricio, Paola Del Bianco, et al.The Oncologist|April 16, 2022
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving NivolumabGiulia Pasello, Martina Lorenzi, Lorenzo Calvetti, et al.European Journal of Cancer (Oxford, England : 1990)|November 11, 2023
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studiesFederica Miglietta, Maria Vittoria Dieci, Tommaso Giarratano, et al.BJU International|July 4, 2014
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient ProgrammeOrazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.Frontiers in Oncology|October 3, 2022
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trialAndrea Antonuzzo, Carla Ida Ripamonti, Fausto Roila, et al.Pageof 7